Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_provenance.
- NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_assertion description "[C-MYC alterations and association with patient outcome in early-stage HER2-positive breast cancer from the north central cancer treatment group N9831 adjuvant trastuzumab trial.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_provenance.
- NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_assertion evidence source_evidence_literature NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_provenance.
- NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_assertion SIO_000772 21245420 NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_provenance.
- NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_assertion wasDerivedFrom befree-2016 NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_provenance.
- NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_assertion wasGeneratedBy ECO_0000203 NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_provenance.
- befree-2016 importedOn "2016-02-19" NP866171.RAqjiC4n22mOfhsMHaRpYhyqP5ZmJ3zbTImv0xDWasfHg130_provenance.